Predictors of progression of light-chain cardiac amyloidosis.

29 August 2017 (15:35 - 16:25)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Vilen Rameev

Moscow (Russian Federation)

6 More presentations in this session

Presentation thumbnail

Comparison of various non-invasive tools for diagnosing AL cardiac amyloidosis.

Mr M. Nicol (Paris, FR)

Abstract Slides

Presentation thumbnail

Investigation of left ventricular function and biomarkers following treatment in patients with light-chain cardiac amyloidosis

Presentation thumbnail

Prognosis of patients with cardiac amyloidosis referred in the French cardiac amyloidosis expert center.

Professor T. Damy (Creteil, FR)

Abstract Slides

Presentation thumbnail

AG10, an orally available, novel transthyretin (TTR) stabilizer: integrated preclinical evaluation predicts a highly effective treatment for TTR amyloid cardiomyopathy

Associate Professor M. Alhamadsheh (Stockton, US)

Presentation thumbnail

Long-term evolution of longitudinal myocardial deformation in the natural history of familial amyloid polyneuropathy

Doctor G. Lima Da Silva (Lisbon, PT)

Abstract Slides

Access the full session

Session thumbnail

Cardiac amyloidosis

The Event

ESC Congress 2017

29 August 2017 15:35 CET

You may be interested in

Congress Session

Amyloidosis - it never comes alone?

18 May 2025

Congress Presentation

Left atrial volume predicts mortality in light-chain amyloidosis

29 June 2021

Congress Presentation

Biomarkers for monitoring patients with cardiac amyloidosis during transthyretin-stabilizer therapy

31 August 2024

Congress Presentation

Amyloid progression or comorbidities? Differentiating management for optimal outcomes

31 August 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources